Showing 71-80 of 325 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Bringing Beta Cell Regenerative Therapy to the Clinic | Icahn School of Medicine at Mount Sinai | Andrew Stewart | Cures | 01-January-2024 to 31-December-2026 | $1,000,000.00 |
| Exploiting SDF2L1 to protect against beta cell death and dysfunction in T1D | Indiana Biosciences Research Institute | Michael Kalwat | Cures | 01-December-2024 to 30-November-2027 | $748,169.00 |
| Genome-scale CRISPR screens identify ER export cargo proteins as mediators for β-cell stress response and antigen presentation | Indiana Biosciences Research Institute | Isabela Lovizutto Iessi Longo | Cures | 01-March-2023 to 28-February-2026 | $135,307.11 |
| ROLE OF ZBED3 IN BETA CELL STRESS RESPONSE AND VULNERABILITY AGAINST AUTOIMMUNITY | Indiana Biosciences Research Institute | Erica Cai | Cures | 01-March-2023 to 29-February-2028 | $999,737.71 |
| Targeting ER cargo proteins for beta cell protection against cellular stress and autoimmunity | Indiana Biosciences Research Institute | Erica Cai | Cures | 01-September-2023 to 31-August-2026 | $499,934.12 |
| A smart Semiconductor based Continuous Diabetes Monitoring Platform | Integrated Medical Sensors Inc | Muhammad Mujeeb-U-Rahman | Improving Lives | 01-June-2022 to 07-November-2025 | $500,000.00 |
| Clinical Translation of T-1123, an Ultra-rapid, Concentrated, Temperature stable Novel Insulin Analog | Invictus Therapeutics, LLC | Robyn Day | Improving Lives | 15-October-2025 to 31-May-2027 | $1,437,112.00 |
| Adult T1D Detection at Geisinger | IQVIA, Inc. | Nadejda Leavitt | Cures | 01-July-2023 to 31-December-2025 | $890,727.00 |
| Advancing T1D Detection and Care Through AI | IQVIA, Inc. | Nadejda Leavitt | Cures | 01-February-2025 to 31-January-2026 | $345,083.00 |
| JDRF-IQVIA Adult T1D Detection | IQVIA, Inc. | Nadejda Leavitt | Cures | 01-October-2022 to 31-August-2025 | $953,780.00 |